SCHEMBL20869031

SCHEMBL20869031

CC(C)(C)OC(=O)NCc1cc(Br)ccc1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.44
KDM4A O75164 1/20 0.44
AAK1 Q2M2I8 7/20 0.44
ALDH1A1 P00352 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
PKM P14618 1/20 0.43
HIF1A Q16665 1/20 0.43
HDAC1 Q13547 1/20 0.43
CA12 O43570 2/20 0.43
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA9 Q16790 2/20 0.43
ANO1 Q5XXA6 1/20 0.43
NPC1 O15118 1/20 0.42
RECQL P46063 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NQO2 P16083 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30101760 1.00 EGFR (0.44) EGFRKDM4AAAK1ALDH1A1CYP1A2
SCHEMBL19201249 0.89 KDM4A (0.44) KDM4AAAK1HDAC1NPC1RECQL
SCHEMBL8011978 0.87 AAK1 (0.47) KDM4AAAK1NPC1RECQLRAB9A
SCHEMBL31142972 0.87 AAK1 (0.47) KDM4AAAK1NPC1RECQLRAB9A
SCHEMBL18719605 0.87 KDM4A (0.45) KDM4AAAK1ALDH1A1NPC1RECQL
SCHEMBL4090969 0.86 EGFR (0.45) EGFRAAK1ALDH1A1CYP1A2CYP3A4
SCHEMBL4471744 0.86 KDM4A (0.44) KDM4AAAK1NPC1RECQLRAB9A
SCHEMBL30101829 0.86 AAK1 (0.46) KDM4AAAK1NPC1RECQLRAB9A
SCHEMBL1476859 0.84 AAK1 (0.47) KDM4AAAK1NPC1RECQLRAB9A
SCHEMBL2520675 0.84 AAK1 (0.46) KDM4AAAK1NPC1RECQLRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019063748-A1 ROR-GAMMA INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2019-04-04 WO disclosed